1337 related articles for article (PubMed ID: 28300280)
1. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.
Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L
J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin inhibits B-cell activating factor (BAFF)-stimulated cell proliferation and survival by suppressing Ca
Zeng Q; Zhou Z; Qin S; Yao Y; Qin J; Zhang H; Zhang R; Xu C; Zhang S; Huang S; Chen L
Cell Calcium; 2020 May; 87():102171. PubMed ID: 32062191
[TBL] [Abstract][Full Text] [Related]
3. BAFF inhibits autophagy promoting cell proliferation and survival by activating Ca
Dong X; Qin J; Ma J; Zeng Q; Zhang H; Zhang R; Liu C; Xu C; Zhang S; Huang S; Chen L
Cell Signal; 2019 Jan; 53():68-79. PubMed ID: 30244168
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin inhibits BAFF-stimulated cell proliferation and survival by suppressing mTOR-mediated PP2A-Erk1/2 signaling pathway in normal and neoplastic B-lymphoid cells.
Zeng Q; Zhang H; Qin J; Xu Z; Gui L; Liu B; Liu C; Xu C; Liu W; Zhang S; Huang S; Chen L
Cell Mol Life Sci; 2015 Dec; 72(24):4867-84. PubMed ID: 26118661
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin prevents cadmium-induced neuronal cell death via targeting both mTORC1 and mTORC2 pathways.
Xu C; Liu C; Liu L; Zhang R; Zhang H; Chen S; Luo Y; Chen L; Huang S
Neuropharmacology; 2015 Oct; 97():35-45. PubMed ID: 26002629
[TBL] [Abstract][Full Text] [Related]
6. Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion.
Chen L; Xu B; Liu L; Liu C; Luo Y; Chen X; Barzegar M; Chung J; Huang S
Oncotarget; 2015 Mar; 6(9):7136-50. PubMed ID: 25762619
[TBL] [Abstract][Full Text] [Related]
7. Metformin prevents BAFF activation of Erk1/2 from B-cell proliferation and survival by impeding mTOR-PTEN/Akt signaling pathway.
Chen X; Ma J; Yao Y; Zhu J; Zhou Z; Zhao R; Dong X; Gao W; Zhang S; Huang S; Chen L
Int Immunopharmacol; 2021 Jul; 96():107771. PubMed ID: 34004440
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity.
Liu L; Luo Y; Chen L; Shen T; Xu B; Chen W; Zhou H; Han X; Huang S
J Biol Chem; 2010 Dec; 285(49):38362-73. PubMed ID: 20937815
[TBL] [Abstract][Full Text] [Related]
9. IL-2, IL-4, IFN-γ or TNF-α enhances BAFF-stimulated cell viability and survival by activating Erk1/2 and S6K1 pathways in neoplastic B-lymphoid cells.
Gui L; Zeng Q; Xu Z; Zhang H; Qin S; Liu C; Xu C; Qian Z; Zhang S; Huang S; Chen L
Cytokine; 2016 Aug; 84():37-46. PubMed ID: 27235588
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection of resveratrol against cadmium-poisoning acts through dual inhibition of mTORC1/2 signaling.
Liu C; Zhang R; Yang L; Ji T; Zhu C; Liu B; Zhang H; Xu C; Zhang N; Huang S; Chen L
Neuropharmacology; 2022 Nov; 219():109236. PubMed ID: 36049535
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol induces autophagy impeding BAFF-stimulated B-cell proliferation and survival by inhibiting the Akt/mTOR pathway.
Yao Y; Zhu J; Qin S; Zhou Z; Zeng Q; Long R; Mao Z; Dong X; Zhao R; Zhang R; Zhang S; Huang S; Chen L
Biochem Pharmacol; 2022 Aug; 202():115139. PubMed ID: 35697119
[TBL] [Abstract][Full Text] [Related]
12. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.
Mi W; Ye Q; Liu S; She QB
Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827
[TBL] [Abstract][Full Text] [Related]
13. hsBAFF promotes proliferation and survival in cultured B lymphocytes via calcium signaling activation of mTOR pathway.
Ke Z; Liang D; Zeng Q; Ren Q; Ma H; Gui L; Chen S; Guo M; Xu Y; Gao W; Zhang S; Chen L
Cytokine; 2013 May; 62(2):310-21. PubMed ID: 23557796
[TBL] [Abstract][Full Text] [Related]
14. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells.
Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR
Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235
[TBL] [Abstract][Full Text] [Related]
15. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.
Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N
BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559
[TBL] [Abstract][Full Text] [Related]
16. Feedback loops blockade potentiates apoptosis induction and antitumor activity of a novel AKT inhibitor DC120 in human liver cancer.
Yang F; Deng R; Qian XJ; Chang SH; Wu XQ; Qin J; Feng GK; Ding K; Zhu XF
Cell Death Dis; 2014 Mar; 5(3):e1114. PubMed ID: 24625973
[TBL] [Abstract][Full Text] [Related]
17. S6K1 regulates hematopoietic stem cell self-renewal and leukemia maintenance.
Ghosh J; Kobayashi M; Ramdas B; Chatterjee A; Ma P; Mali RS; Carlesso N; Liu Y; Plas DR; Chan RJ; Kapur R
J Clin Invest; 2016 Jul; 126(7):2621-5. PubMed ID: 27294524
[TBL] [Abstract][Full Text] [Related]
18. BAFF activates Erk1/2 promoting cell proliferation and survival by Ca2+-CaMKII-dependent inhibition of PP2A in normal and neoplastic B-lymphoid cells.
Liang D; Zeng Q; Xu Z; Zhang H; Gui L; Xu C; Chen S; Zhang S; Huang S; Chen L
Biochem Pharmacol; 2014 Jan; 87(2):332-43. PubMed ID: 24269630
[TBL] [Abstract][Full Text] [Related]
19. Receptor-recognized α₂-macroglobulin binds to cell surface-associated GRP78 and activates mTORC1 and mTORC2 signaling in prostate cancer cells.
Misra UK; Pizzo SV
PLoS One; 2012; 7(12):e51735. PubMed ID: 23272152
[TBL] [Abstract][Full Text] [Related]
20. A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin.
Huang Y; Xi Q; Chen Y; Wang J; Peng P; Xia S; Yu S
Anticancer Drugs; 2013 Oct; 24(9):889-98. PubMed ID: 23838676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
